ScreenPoint Medical

ScreenPoint Medical is a Netherlands-based startup that specializes in AI and machine learning for early breast cancer detection. Its flagship product, Transpara, has garnered attention for its success in over 35 peer-reviewed publications, showcasing consistent results across diverse patient demographics. The company's utilization of cutting-edge machine learning techniques, including Deep Learning and large, well-curated databases, contributes to its goal of matching and surpassing expert radiologists' performance. With its recent $28.00M Series C investment led by Insight Partners, Oost NL, and Siemens Healthineers on July 27, 2021, ScreenPoint Medical is poised for further advancements in the domain of breast cancer detection.